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Antimicrobial use and planetary health: developing a 
framework for priorities 
Increased strategic thinking is needed about antimicrobial 
use and antimicrobial resistance (AMR), which has 
been termed the quintessential One Health challenge1 
and compared to greenhouse gas emissions (GHG) 
mitigation or abatement.2 The parallels between 
these wicked problems are indeed striking. AMR is 
characterised by market and institutional failures in 
terms of externalised costs by antimicrobial users and the 
absence of global regulatory or governance architecture. 
Multiple human and animal sources of antimicrobial 
pollution exist that are further complicated by complex 
environmental interactions, pooling, and persistence. 
Multiple potential entry points could be used to modify 
clinical and veterinary uses of medicines and detect and 
diagnose AMR. Many interventions complement or 
interact in unanticipated ways and the human dimension 
to antimicrobial use raises unresolved behavioural 
challenges. Finally, political economy dimensions can 
create conflicts between public and private sector 
interests and the interests of developed and developing 
countries. These conflicts can inhibit innovation and the 
adoption of even the most technically effective measures. 
Overall, the science policy discourse can seem incoherent 
and overwhelming. Recourse to One Health, planetary 
boundary, or ecosystem service rhetoric can only go so far. 
An immediate question is what to do first, or how to set 
priorities for action, on the basis of a consensus of what is 
and isn’t known.  
This situation is reminiscent of the climate change 
experience. A decade ago, much unstructured discussion 
occurred around different GHG abatement measures, 
but an understanding of the relative cost of avoiding 
a tonne of carbon dioxide equivalent emission was 
unclear. Some governments took the initiative to develop 
a more rational approach to the problem, drawing 
on environmental economics and related theories of 
pollution control to develop marginal abatement cost 
curves (MACCs) to rank cost competitive interventions.3 
This information provided a basis for estimating 
carbon budgets sector by sector by comparing marginal 
abatement costs. This comparison includes agriculture 
which is a biophysically complex sector for seeking 
GHG mitigation. Could adopting a similar approach 
for the identification of cost-effective ways to reduce 
antimicrobial use, if not AMR outcomes, be beneficial? 
MACCs form a framework to cumulate data on 
effectiveness and to measure implementation cost to 
estimate technical or economic and feasible mitigation 
potentials, the latter being mitigation achievable with 
existing or potential policy instruments and behavioural 
barriers. For given assumptions inherent in their 
construction, MACCs help frame numerous questions 
for research and policy, including: what are the known 
feasible abatement measures, how do they work, and 
what is their current baseline use; to what extent can 
measures be applied (alone and in combination) and with 
what approximate outcome above baseline; what are the 
costs including any ancillary effects; which measures are 
relatively cost-effective including win-win measures (ie, 
implying negative or cost savings); which policies apply to 
which measures; and which measures need more research, 
are relatively uncertain, or out of scope because of cost or 
policy and regulatory feasibility?  
The climate experience shows the value of an analytical 
framework to organise disparate information and 
to improve scientific dialogue, consensus, and policy 
evidence on what is known. Development of a MACC is 
typically multidisciplinary, collaborative, and evolutionary, 
allowing stakeholders to clarify assumptions, add and 
scrutinise measures, and validate input data. Such 
frameworks offer a template for focusing discussion across 
public and private sectors nationally and internationally.  
AMR research and policy urgently needs a similar 
framework to focus efforts and to organise information 
on entry points applicable at different scales (eg, farm, 
production unit, supply chain, and region or country for 
antimicrobial use in agriculture). A conspicuous gap in 
global efforts to combat AMR exists. An international 
scientific collaboration to advance this agenda makes 
sense for transparency and impartiality. Climate change 
mitigation has shown the way.
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